Sofia, Bulgaria, September 20, 2023 – According to the requirements of art. 100t of LPOS, “Sopharma” AD notifies that for the month of August 2023, the Company realized an increase in sales of 19% compared to the same month of the previous year, incl. 17% decrease in domestic sales and 43% increase in export sales.

For the eight months from the beginning of 2023, sales increased by a total of 14%, incl. a 4% decrease in domestic sales and a 27% increase in export sales.